Program

Thank you for your interest in the AMP 2021 Annual Meeting & Expo!

The AMP 2021 Program Committee has been working hard to plan a comprehensive program, which we hope will encourage dialogue and foster discussion amongst attendees.

 

Preliminary Program:

Be sure to check back for updated Program information often!

Quick Links

Thursday

Friday

Saturday

 

Tuesday, November 16, 2021

GENERAL INFORMATION

8:30am - 3:45pm

SHORT COURSE DAY

AMP Reference Materials Forum

Guest Society Symposia

Pre-Meeting Workshops 

11:30am - 6:00pm

Board of Directors Meeting (Invitation Only)

4:00pm - 7:00pm

Attendee, Speaker, and Exhibitor Registration and Check-In

6:30pm

Board of Directors Dinner (Invitation Only)

 

Wednesday, November 17, 2021

GENERAL INFORMATION

7:00am - 5:00pm

Attendee, Speaker, and Exhibitor Registration and Check-In

7:30am - 3:00pm

GetAMPed! (Separate Registration)

7:30am - 5:00pm

Committee Meetings (Invitation Only)

8:00am - 5:00pm

Corporate Workshop Day (No Registration Required!)

6:00pm - 7:00pm

Volunteer Appreciation Reception (Invitation Only)

 

Thursday, November 18, 2021

GENERAL INFORMATION

6:30am - 8:00am

Poster Set-Up

7:00am - 5:00pm

Attendee, Speaker, and Exhibitor Registration and Check-In

7:00am - 8:00am

Continental Breakfast

11:30am - 4:30pm

Expo Hall Open

5:45pm - 7:00pm

Welcome Reception (In the Expo Hall)

SCIENTIFIC INFORMATION

6:30am - 8:00am

Independent Satellite Symposia

8:00am - 8:15am

Break

8:15am - 8:30am

Opening Remarks

8:30am - 9:45am

AMP Award for Excellence in Molecular Diagnostics: Presentation and Lecture

9:45am -10:00am

Coffee Break

10:00am - 11:30am

CONCURRENT SYMPOSIA SESSIONS

How to Weather the Next Pandemic: Lessons Learned from the COVID-19 EUA Process 

Panel Discussion

Jasmine Chaitram, MPH, MT (ASCP), CDC Division of Laboratory Systems, Atlanta, GA, USA

Karen L. Kaul, MD, PhD, NorthShore University Health System, Evanston, IL, USA

Timothy Stenzel, MD, PhD, US Food and Drug Administration, Rockville, MD, USA

New Insights into Cancer Biology from DNA Mutational Signatures

The Repertoire of Mutational Signatures in Human Cancer

Ludmil B. Alexandrov, PhD, University of California San Diego, La Jolla, CA, USA

Ongoing efforts to identify causes of currently unexplained signatures

Serena Nik-Zainal, MD, PhD, University of Cambridge, Cambridge, United Kingdom

11:30am - 12:45pm

General Lunch - Visit Expo Hall and View Posters

12:45pm - 2:00pm

CONCURRENT BREAKOUT SESSIONS

Low Coverage Whole Genome Sequencing

Low-pass Genome Sequencing and Polygenic Risk Scores

Joe Pickrell, Gencove, New York, NY, USA

Low Coverage Whole Genome Sequencing

Julian Homburger, PhD, Color Health, Alamo, CA, USA

Alternative Perspectives to Multi-omics Single-cell Analysis

Alternative Perspectives to Multi-omics Single-cell Analysis

Robert B. Faryabi, PhD, MSc, University of Pennsylvania School of Medicine, Philadelphia, PA, USA

The Changing Landscape of Reimbursement for Pathology Clinical Consultation and Impact on Interpretation of Tumor Genomics

Current landscape of coding and reimbursement for tumor genomics interpretation and clinical correlation and consultation

Samuel K. Caughron, MD, MAWD Pathology Group, Lenexa, KS, USA

Tracking the Global Spread of Mutli-Drug Resistant Organisms

The Genomics, Evolution, and Spread of Drug-resistant Neisseria gonorrhoeae

Yonatan Grad, MD, PhD, Harvard Chan School of Public Health, Boston, MA, USA

Tracking the Global Spread of Mutli-Drug Resistant Organisms

Paul J. Planet, MD, PhD, University of Pennsylvania and Children's Hospital of Philadelphia, Philadelphia, PA, USA

New Developments in Mitochondrial DNA Variant Identification and Classification 

Mitochondrial DNA Variant Classification and MITOMAP

Marni J. Falk, MD, Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA

2:00pm - 3:45pm

Coffee Break - Visit Expo Hall and View Posters

3:45pm - 4:30pm

AMP Working Group Meetings

4:30pm- 4:45pm

Break

4:45pm - 5:45pm

PLENARY SESSION

MRD for Lymphoma Beyond Immunoglobulin

Ash Alizadeh, MD, PhD, Color Health, Stanford, CA, USA

5:45pm - 7:00pm

Welcome Reception (In the Expo Hall)

 

Friday, November 19, 2021

GENERAL INFORMATION

7:00am - 5:00pm

Attendee, Speaker, and Exhibitor Registration and Check-In

7:00am - 8:00am

Continental Breakfast

9:00am - 4:00pm

Expo Hall Open

SCIENTIFIC INFORMATION

7:30am - 8:30am

TARGETED TOPICS

Case Studies

Perspectives on Tumor Mutational Burden: An Update from the AMP TMB Working Group

Larissa V. Furtado, MD, St. Jude Children’s Research Hospital, Memphis, TN, USA

Lauren Ritterhouse, MD, PhD, Massachusetts General Hospital, Andover, MA, USA

Utilization of NGS Testing in Cytopathology Samples

Hamza N. Gokozan, MD, Weill Cornell Medicine, New York, NY, USA

Mitochondrial DNA as Clonal Markers to Infer and Track Clonal Mosaicism 

Vijay G. Sankaran, MD, PhD, Boston Children's Hospital/ Harvard Medical School, Boston, MA, USA

8:30am - 8:45am

Break

8:45am - 9:45am

PLENARY SESSION

How Far are We from an HIV Cure?  Implications for Molecular Diagnostics 

Pathways Towards an HIV Cure? Implications for Molecular Diagnostics

Deborah Persaud, MD, Johns Hopkins University School of Medicine, Baltimore, MD, USA

9:45am - 10:45am

Coffee Break - Visit Expo Hall and View Posters

(Even-numbered posters Attended)

10:45am - 12:15pm

CONCURRENT BREAKOUT SESSIONS

Negotiating in a Hostage Situation: Tips to Keep Your Lab Financially Solvent During COVID-19 and the Next Pandemic

Matt Charles, MPH, Northshore University HealthSystem, Chicago, IL, USA

Donna Wolk, Geisinger, Danville, PA , USA

Promises & Pitfalls of EHR-based Variant Reanalysis 

Variant Reclassification and Reinterpretation - Challenges and Opportunities in Current and Future EHR Usability and Function

Alexis Carter, MD, Children’s Healthcare of Atlanta, Atlanta, GA, USA

Improvement and Challenges of EHR System and Integration of Genomic Data

Alexis Carter, MD, Children’s Healthcare of Atlanta, Atlanta, GA, USA

Considerations for the Optimal Detection of Clinically Relevant Fusions in Solid Tumors 

Overview of the Various Methodologies for Fusion Detection in a Clinical Laboratory

John Iafrate, MD, PhD, Massachusetts General Hospital, Boston, MA, USA

Clinical Fusion Detection Approaches and Methodologies

Susan Hsiao, MD, PhD, Columbia University Medical Center, New York, NY, USA

Use of in Silico Data for Pipeline Development/Validation 

Sabah Kadri, Lurie Children's Hospital of Chicago, Chicago, IL, USA

Genetic Healthcare Disparities

Social Implications of Genetic Diagnosis and Therapies

John Carpten, PhD, University of Southern California, Los Angeles, CA, USA

Enabling Precision Medicine for Diverse Populations

Lucia Hindorff

Lack of Diversity in Genomics and Implications for Clinical Genetics

Alice B. Popejoy, PhD, University of California, Davis, Sacramento, CA, USA

12:15pm - 1:30pm

General Lunch - Visit Expo Hall and View Posters

1:30pm - 3:00pm

CONCURRENT SYMPOSIA SESSIONS

Perspectives on the Applications of SARS CoV-2 Genome Sequencing

Panel Discussion

Jennifer Dien Bard, PHD, Children's Hospital of Los Angeles;  Keck School of Medicine, USC, South Pasadena, CA, USA

Kirsten St. George, M.App.Sc., PHD, Department of Health, Wadsworth Center, Albany, NY???????, USA

Applications of Therapeutic Gene Editing 

Development and Application of Genome Editing Technologies

Fyodor Urnov, PhD, University of California, Berkeley, CA, USA

Gene Editing for the Treatment of Red Blood Cell Disorders

Haydar Frangoul, MD, Sarah Cannon Center for Blood Cancer, Nashville, TN, USA

3:00pm - 4:00pm

Coffee Break - Visit Expo Hall and View Posters

4:00pm - 5:00pm

PLENARY SESSION

At the Intersection of Precision Medicine and Machine Learning 

Eliezer Van Allen, MD, Dana Farber Cancer Institute, Brookline, MA, USA

5:00pm - 5:15pm

Break

5:15pm - 6:15pm

Business Meeting and Awards Session

(Open to All Registered Attendees)

7:00pm - 10:30pm

Social Event

(Separate Registration)

 

 

Saturday, November 20, 2021

GENERAL INFORMATION

7:00am - 2:00pm

Attendee, Speaker, and Exhibitor Registration and Check-In

7:00am - 8:00am

Continental Breakfast

9:00am - 1:30pm

Expo Hall Open

12:30pm - 1:30pm

Poster Removal

SCIENTIFIC INFORMATION

7:30am - 8:30am

TARGETED TOPICS

Case Studies

Platform Presentations of Selected Technical Topics Abstracts

Difficult to Sequence Regions in the Genome 

Description of Hard to Sequence Regions

Justin M. Zook, PhD, NIST, Gaithersburg, MD, USA

Informatics Solutions to Difficult to Sequence Regions

Karen Miga

Advanced Sequencing Applications in the Public Health Laboratory

Molecular Streptococcus Pneumoniae Serotyping

Sara Vetter, PhD, D(ABMM), Minnesota State Public Health Laboratory, St. Paul, MN, USA

How NGS Is Used for Outbreak Detection

Heather Carleton, CDC, Atlanta, GA, USA

8:30am - 8:45am

Break

8:45am - 9:45am

PLENARY SESSION

Advances in Clinical Applications for Complex Genetic Disorders 

From Reading the Genome for Risk to Rewriting it for Cardiovascular Health

Sekar Kathiresan, MD, Verve Therapeutics, Cambridge, MA, USA

9:45am - 10:45am

Coffee Break - Visit Expo Hall and View Posters

(Odd-numbered posters Attended)

10:45am - 12:15pm

CONCURRENT BREAKOUT SESSIONS

Molecular Diagnostics in the Community Hospital: How to Offer Complete and Up to Date Testing

Overview of Provision and Utilization of Molecular Testing in Community Cancer Centers, Ideally from an Individual Involved in the Association of Community Cancer Centers

Tabetha Sundin, PhD, HCLD (ABB), MB (ASCP)CM, AstraZeneca, Middletown, MD, USA

Experience from Molecular Pathologists Running Laboratories in a Community or Non-academic Setting, Discussing How They've Chosen What Types of Molecular Testing to Provide and How They Have Established Their Role in the Larger Molecular Laboratory Ecosystem

Michelle Shiller, DO, AP/CP, MGP, Baylor Scott & White Health, Dallas, TX, USA

Novel Insights into Clonal Hematopoiesis

Link Between Cancer Therapy and Clonal Hematopoiesis

Ahmet Zehir, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Rationale for screening stem cell donors for clonal hematopoiesis

Lukasz Gondek

Rationale for not screening stem cell donors for clonal hematopoiesis

Coleman Lindsley, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, USA

Pharmacogenomic Testing Across Populations 

Pharmacogenomics Implementation Across Populations in North America

Deepak Voora, MD, Duke University, Durham, NC, USA

Implementation of Pharmacogenetics in Clinical Care: an EU perspective

Ron HN Van Schaik, PhD, Erasmus MC, Rotterdam, Zuid-Holland, Netherlands

Pharmacogenomics in Pediatrics

Laura B. Ramsey, PhD, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA

Cool New Tech for At-Home Testing

Rapid, Point-of-Care Diagnostics

Catherine Klapperich, PhD, Boston University, Brookline, MA, USA

Cool New Tech for At-Home Testing

Jonathan Posner

Cool New Tech for At-Home Testing

Melanie Ott, MD, PhD, Gladstone Institute of Virology and UCSF, San Francisco, CA, USA

12:15pm - 1:30pm

General Lunch - Visit Expo Hall, and View Posters

1:30pm - 2:30pm

CONCURRENT BREAKOUT SESSIONS

Platform Presentations of Selected Abstracts

Abstracts are selected by the Program Committee

Platform Presentations of Selected Genetics Abstracts

Platform Presentations of Selected Hematopathology Abstracts

Platform Presentations of Selected Infectious Diseases Abstracts

Platform Presentations of Selected Informatics Abstracts

Platform Presentations of Selected Solid Tumors Abstracts

 

2:30pm - 2:45pm

Break

2:45pm - 4:15pm

CONCURRENT SYMPOSIA SESSIONS

Liquid Biopsy and MRD

Use of Patient Specific Panels for MRD Detection

Viktor Adalsteinsson, PhD, Broad Institute of MIT and Harvard, Wakefield, MA, USA

Use of Methylation Signatures for MRD Detection

Dan Landau, MD, PhD, Weill Cornell Medicine, New York, NY, USA

New Applications of CAR T-Cells

CAR T-cell therapies for autoimmune diseases

Michael Milone

“Mechanisms of CAR T cells”

Macela Maus, MD, PhD, Massachusetts General Hospital East, Charlestown, MA, USA

Practical Issues with Quantitative Molecular Testing for Infectious Diseases

Validation of Samples Shared Between Molecular and Other Testing Platforms

Rebecca Harris, University of Pennsylvania and Children's Hospital of Philadelphia, Philadelphia, PA, USA

CMV Viral Load Testing

Randall Hayden, MD, St. Jude Children's Research Hospital, Memphis, TN, USA

Practical Considerations to Optimize Algorithmic Testing for the Diagnosis of HIV

Blake W. Buchan, PhD, Medical College of Wisconsin, Milwaukee, WI, USA

4:15pm - 4:30pm

Break

4:30pm - 5:30pm

PLENARY SESSION

Mutational Processes in Cancer Cells and Normal Cells 

Mutational Signature Analysis and its Application to the Clinic

Peter J. Park, PhD, Harvard Medical School, Boston, MA, USA

5:30pm - 5:45pm

Closing Remarks